50.22

1.60% 0.79

After Hours: 50.35 0.13 +0.26%

Dupont De Nemours Inc (DD)

Overview News Price History Option Chain Financials Why DD Down? Discussions Forecast Stock Split Dividend History

Dupont De Nemours Inc stock is traded at $50.22, with a volume of 4.24M. It is up +1.60% in the last 24 hours and up +14.68% over the past month. DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.

Previous Close:

$49.43

Open:

$49.42

24h Volume:

4.24M

Relative Volume:

0.82

Market Cap:

$20.55B

Revenue:

$12.61B

Net Income/Loss:

$109.00M

P/E Ratio:

-107.61

EPS:

-0.4667

Net Cash Flow:

$1.32B

1W Performance:

+7.47%

1M Performance:

+14.68%

6M Performance:

-32.13%

1Y Performance:

-40.25%

1-Day Range:

$48.90

$50.30

1-Week Range:

$46.33

$52.66

52-Week Range:

$33.34

$85.00

Dupont De Nemours Inc Stock (DD) Company Profile

Name

Dupont De Nemours Inc

Sector

Basic Materials (270)

Industry

Specialty Chemicals (58)

Phone

(302) 295-5783

Address

974 CENTRE ROAD, WILMINGTON, DE

Employee

24,000

Twitter

@dupont_news

Next Earnings Date

2025-05-02

Latest SEC Filings

DD's Discussions on Twitter

Compare DD vs LIN, SHW, ECL, APD, PPG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DD Dupont De Nemours Inc	50.22	20.23B	12.61B	109.00M	1.32B	-0.4667
LIN Linde plc Ordinary Share	481.00	220.80B	33.99B	7.06B	5.06B	14.59
SHW Sherwin Williams Co	368.89	92.37B	23.57B	2.57B	2.43B	10.26
ECL Ecolab Inc	299.17	85.17B	16.08B	2.09B	1.55B	7.2773
APD Air Products Chemicals Inc	279.74	64.90B	12.21B	-304.80M	-2.81B	-1.5006
PPG Ppg Industries Inc	131.34	29.52B	15.88B	1.59B	725.00M	6.9113

Dupont De Nemours Inc Stock (DD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-03-25	Reiterated	Citigroup	Buy
Apr-15-25	Upgrade	BofA Securities	Underperform → Neutral
Apr-14-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Feb-13-25	Upgrade	Barclays	Underweight → Equal Weight
Jan-17-25	Upgrade	Wolfe Research	Peer Perform → Outperform
Oct-07-24	Downgrade	Barclays	Equal Weight → Underweight
May-28-24	Upgrade	Citigroup	Neutral → Buy
May-24-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-23-24	Upgrade	BMO Capital Markets	Market Perform → Outperform
May-17-24	Upgrade	Jefferies	Hold → Buy
Mar-01-24	Initiated	Wolfe Research	Peer Perform
Jan-24-24	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jan-24-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-16-24	Downgrade	BofA Securities	Buy → Underperform
Jul-19-23	Reiterated	Citigroup	Neutral
Jun-14-23	Initiated	Citigroup	Neutral
May-15-23	Upgrade	Deutsche Bank	Hold → Buy
Jan-17-23	Downgrade	Deutsche Bank	Buy → Hold
Jan-12-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Dec-20-22	Resumed	JP Morgan	Overweight
Jun-16-22	Downgrade	Jefferies	Buy → Hold
Feb-09-22	Reiterated	Barclays	Equal Weight
Feb-09-22	Reiterated	BofA Securities	Buy
Feb-09-22	Reiterated	Citigroup	Buy
Feb-09-22	Reiterated	Deutsche Bank	Buy
Feb-09-22	Reiterated	Mizuho	Buy
Nov-03-21	Upgrade	Credit Suisse	Neutral → Outperform
Nov-03-21	Upgrade	Vertical Research	Hold → Buy
Oct-13-21	Initiated	Mizuho	Buy
Oct-04-21	Upgrade	JP Morgan	Neutral → Overweight
Jul-06-21	Resumed	Credit Suisse	Neutral
May-26-21	Resumed	Morgan Stanley	Equal-Weight
May-11-21	Upgrade	Goldman	Neutral → Buy
Mar-22-21	Initiated	Barclays	Equal Weight
Feb-11-21	Upgrade	DZ Bank	Sell → Hold
Feb-03-21	Upgrade	BofA Securities	Neutral → Buy
Jan-28-21	Downgrade	Exane BNP Paribas	Outperform → Neutral
Jan-27-21	Downgrade	Susquehanna	Positive → Neutral
Jan-21-21	Downgrade	BofA Securities	Buy → Neutral
Jan-14-21	Downgrade	DZ Bank	Buy → Sell
Jan-14-21	Downgrade	JP Morgan	Overweight → Neutral
Jan-13-21	Downgrade	HSBC Securities	Buy → Hold
Jan-13-21	Downgrade	Vertical Research	Buy → Hold
Aug-03-20	Downgrade	Stephens	Overweight → Equal-Weight
Jun-25-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-19-20	Reiterated	Wells Fargo	Overweight
Apr-29-20	Resumed	Wells Fargo	Overweight
Apr-20-20	Upgrade	JP Morgan	Neutral → Overweight
Mar-26-20	Initiated	KeyBanc Capital Markets	Overweight
Jan-14-20	Initiated	Gordon Haskett	Buy
Jan-06-20	Initiated	JP Morgan	Neutral
Dec-17-19	Reiterated	Cowen	Outperform
Nov-15-19	Reiterated	Cowen	Outperform
Sep-10-19	Initiated	Jefferies	Buy
Aug-30-19	Upgrade	Exane BNP Paribas	Neutral → Outperform
Aug-20-19	Reiterated	Cowen	Outperform
Jun-25-19	Resumed	Monness Crespi & Hardt	Neutral
Jun-10-19	Initiated	Cowen	Outperform

View All

Dupont De Nemours Inc Stock (DD) Latest News

Feb 14, 2026

What is DuPont de Nemours Inc.’s book value per shareWeekly Risk Report & Low Volatility Stock Recommendations - mfd.ru

Feb 14, 2026

DuPont (DD) Surpasses Expectations with Strong Q4 Results - GuruFocus

Feb 14, 2026

Feb 13, 2026

Will DuPont de Nemours Inc. benefit from sector rotationJuly 2025 Opening Moves & Weekly High Return Opportunities - mfd.ru

Feb 13, 2026

DuPont targets 3% organic sales growth and $2.25–$2.30 EPS for 2026 as portfolio transformation accelerates - MSN

Feb 13, 2026

Mold Inhibitors Market Size to be Valued at USD 2.20 Billion by 2033 Owing to the Surging Demand for Natural and Clean-Label Preservatives Among Applications Globally - GlobeNewswire Inc.

Feb 13, 2026

Feb 12, 2026

BMO Capital raises DuPont stock price target to $60 on healthcare growth By Investing.com - Investing.com Nigeria

Feb 12, 2026

DuPont (DD) Receives Rating Update from BMO Capital | DD Stock N - GuruFocus

Feb 12, 2026

DuPont Named Finalist in 2026 Edison Awards for FilmTec Fortilife XC160UHP Membrane for Wastewater Treatment and Reuse - Finviz

Feb 12, 2026